CrossRef Comparative efficacy and safety of first-line treatments for advanced hepatocellular carcinoma: a Bayesian network meta-analysis Yun Su, Tongze Cai, Jingxuan Wei, Qiuju Huang, Chun Yao, Lei Fu, Jinghui Zheng, Hongwei Guo, Xiongbin Gui Frontiers in Immunology .2026;[Epub] CrossRef National and regional lifetime risks of developing and dying from digestive system cancers in China: Findings of the Global Burden of Disease Study 2023 Qian Mao, Zhenping Zhao, Jiangmei Liu, Yuchang Zhou, Maigeng Zhou Chinese Medical Journal .2026;[Epub] CrossRef Diagnostic Accuracy of Extracellular versus Hepatobiliary Contrast-enhanced MRI in LI-RADS Nonradiation Treatment Response Algorithm Version 2024 Subin Heo, Yong Jun Jung, Eun Sun Choi, Sehee Kim, Kyoung Won Kim, Young-In Yoon, Hyung Jin Won, Yong Moon Shin, Dong Hwan Kim, Sang Hyun Choi Radiology .2026;[Epub] CrossRef RealWorld Evidence on the Efficacy of Icaritin for Unresectable Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study Dinghu Zhang, Qinfen Xie, Zhewei Zhang, Song Wang, Jibing Liu, Xiang An, Kangshou Liu, Zhengping Yu, Huiling Xiang, Qiang He, Xin Zheng, Zukuan Chang, Ruijie Du, Li Zhang, Gong Li, Qingyu Xu, Wenjie Song, Bin Jin, Chongzhong Liu, Jianjun Li, Xu Zhou, Wenb International Journal of Cancer .2026;[Epub] CrossRef Comparable Long-Term Survival After Curative Hepatectomy for Solitary Large (510 cm) versus Giant (10 cm) Hepatocellular Carcinoma: A Retrospective Study Kunyuan Jiang, Jingfei Li, Dongli Zhang, Weiping Wang, Jun Chang Journal of Hepatocellular Carcinoma .2026
This makes you feel full longer and can reduce your appetite significantly
Cost, side effects, availability, needle aversion, or medical considerations can all lead people to look for other options
Plan for 5-15 pounds as your body adjusts to lack of pharmacological support Hunger will be significantly higher off medication
By leveraging its proprietary technology platform, 50-state medical group, and nationwide mail-order pharmacy network, LifeMD is increasing access to amazing healthcare that is affordable to everyone
No documented FDA warning letter or enforcement action against the company
